Related references
Note: Only part of the references are listed.Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better?
John H. Strickler et al.
CLINICAL CANCER RESEARCH (2021)
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy
Matthias Gromeier et al.
NATURE COMMUNICATIONS (2021)
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages
John de Groot et al.
NEURO-ONCOLOGY (2020)
Mechanisms and therapeutic implications of hypermutation in gliomas
Mehdi Touat et al.
NATURE (2020)
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration
Martina Ott et al.
JCI INSIGHT (2020)
Clonality of CD4+ Blood T Cells Predicts Longer Survival With CTLA4 or PD-1 Checkpoint Inhibition in Advanced Melanoma
Akiko Arakawa et al.
FRONTIERS IN IMMUNOLOGY (2019)
CD4+ T Cell Help Is Required for the Formation of a Cytolytic CD8+ T Cell Subset that Protects against Chronic Infection and Cancer
Ryan Zander et al.
IMMUNITY (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Arginine Deprivation Therapy: Putative Strategy to Eradicate Glioblastoma Cells by Radiosensitization
C. Noreen Hinrichs et al.
MOLECULAR CANCER THERAPEUTICS (2018)
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Karolina Woroniecka et al.
CLINICAL CANCER RESEARCH (2018)
Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different
Chung-Han Lee et al.
TRENDS IN IMMUNOLOGY (2018)
Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models
Vassilis Genoud et al.
ONCOIMMUNOLOGY (2018)
Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM
Justyna Magdalena Przystal et al.
CELL DEATH & DISEASE (2018)
Qki deficiency maintains sternness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation
Takashi Shingu et al.
NATURE GENETICS (2017)
Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy
Tiffany R. Hodges et al.
NEURO-ONCOLOGY (2017)
RANDOMIZED PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF NIVOLUMAB VS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: CHECKMATE 143
D. A. Reardona et al.
NEURO-ONCOLOGY (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Comprehensive analysis of PD-L1 expression in glioblastoma multiforme
Dieter Henrik Heiland et al.
ONCOTARGET (2017)
Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
Casey R. Ager et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Whole-exome somatic mutation analysis of mouse cancer models and implications for preclinical immunomodulatory drug development
Bruno Zeitouni et al.
CANCER RESEARCH (2017)
Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma
M. A. Qazi et al.
ANNALS OF ONCOLOGY (2017)
The Microenvironmental Landscape of Brain Tumors
Daniela F. Quail et al.
CANCER CELL (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
PD-L1 expression and prognostic impact in glioblastoma
Edjah K. Nduom et al.
NEURO-ONCOLOGY (2016)
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
David A. Reardon et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
Eric Bouffet et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The role of microglia and macrophages in glioma maintenance and progression
Dolores Hambardzumyan et al.
NATURE NEUROSCIENCE (2016)
Endogenous Neoantigen-Specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics Approach
Tanner M. Johanns et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Glioblastoma recurrence patterns near neural stem cell regions
Linda Chen et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
Arginine deprivation affects glioblastoma cell adhesion, invasiveness and actin cytoskeleton organization by impairment of β-actin arginylation
Iuliia Pavlyk et al.
AMINO ACIDS (2015)
Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells
Akemi Kosaka et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier
Isabelle St-Amour et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA
An-Jou Chen et al.
GENES & DEVELOPMENT (2012)
Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma
Tiffany A. Doucette et al.
NEURO-ONCOLOGY (2012)
L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1
Lin Cheng et al.
EMBO JOURNAL (2011)
A2B5 Cells from Human Glioblastoma have Cancer Stem Cell Properties
Aurelie Tchoghandjian et al.
BRAIN PATHOLOGY (2010)
High-Resolution Genomic Copy Number Profiling of Glioblastoma Multiforme by Single Nucleotide Polymorphism DNA Microarray
Dong Yin et al.
MOLECULAR CANCER RESEARCH (2009)
Reliable prediction of T-cell epitopes using neural networks with novel sequence representations
M Nielsen et al.
PROTEIN SCIENCE (2003)
The enhanced green fluorescent protein (eGFP) is minimally immunogenic in C57BL/6 mice
D Skelton et al.
GENE THERAPY (2001)
Share Paper
